{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-009867","form_type":"8-K","ticker":"CLPT","cik":"0001285550","company_name":"ClearPoint Neuro, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.709516+00:00","generated_at":"2026-05-16T10:47:29.776992+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ClearPoint Neuro Q4 2025 prelim revenue $10.4M (+20% YoY); FY2026 guidance $54-60M","bullets":["Q4 2025 preliminary unaudited revenue ~$10.4M, 20% comparable sales growth over Q4 2024, excluding recent IRRA flow acquisition.","Full year 2025 preliminary revenue ~$37M.","FY2026 revenue guided at $54-60M, driven by organic growth and IRRA flow product integration.","Q4 segment growth: functional neurosurgery disposables +23%, biologics/drug delivery +26%.","Preliminary results subject to revision; audited results expected later in Q1 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-009867","json":"https://secwatch.observer/filing/0001193125-26-009867.json","markdown":"https://secwatch.observer/filing/0001193125-26-009867.md","text":"https://secwatch.observer/filing/0001193125-26-009867.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526009867/0001193125-26-009867-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1285550/000119312526009867/clpt-20260112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:47:29.776992+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}